SCHEMBL22938933

SCHEMBL22938933

CCN(N)Cc1cccnc1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 3/20 0.68
▸ CHRNA4 P43681 3/20 0.68
▸ CHRNA7 P36544 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ RIPK1 Q13546 1/20 0.48
▸ CYP2A6 P11509 1/20 0.46
▸ NR1H2 P55055 1/20 0.46
▸ NR1H3 Q13133 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ GRM2 Q14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227025 0.88 CHRNB2 (0.64) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL12853934 0.81 CHRNB2 (0.68) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL6674571 0.81 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL31044635 0.81 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL12197592 0.81 CHRNB2 (0.72) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL10509238 0.81 CHRNB2 (0.72) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL27771997 0.76 CHRNB2 (0.59) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL10028665 0.76 CHRNB2 (0.85) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL30632262 0.76 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1
SCHEMBL3460939 0.76 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA7TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021017068-A1 PYRROLO-PYRAZOL DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 上海美迪西生物医药股份有限公司 2021-02-04 — — WO disclosed
Send feedback